Michael Lane - 14 Feb 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane
Issuer symbol
IDXX
Transactions as of
14 Feb 2024
Net transactions value
-$158,638
Form type
4
Filing time
16 Feb 2024, 17:56:27 UTC
Previous filing
08 Nov 2023
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +181 +3.1% $0.000000 5,968 14 Feb 2024 Direct F1
transaction IDXX Common Stock Options Exercise $0 +173 +2.9% $0.000000 6,141 14 Feb 2024 Direct
transaction IDXX Common Stock Options Exercise $0 +161 +2.6% $0.000000 6,302 14 Feb 2024 Direct
transaction IDXX Common Stock Options Exercise $0 +204 +3.2% $0.000000 6,506 14 Feb 2024 Direct
transaction IDXX Common Stock Options Exercise $0 +220 +3.4% $0.000000 6,726 14 Feb 2024 Direct
transaction IDXX Common Stock Tax liability $158,638 -283 -4.2% $560.56 6,443 14 Feb 2024 Direct
holding IDXX Common Stock 592 14 Feb 2024 by spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +5,407 $0.000000 5,407 14 Feb 2024 Common Stock 5,407 $560.56 Direct F3
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +178 $0.000000 178 14 Feb 2024 Common Stock 178 $560.56 Direct F4
transaction IDXX Restricted Stock Unit Award $0 +1,204 $0.000000 1,204 14 Feb 2024 Common Stock 1,204 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -181 -100% $0.000000* 0 14 Feb 2024 Common Stock 181 Direct F6
transaction IDXX Restricted Stock Unit Options Exercise $0 -173 -100% $0.000000* 0 14 Feb 2024 Common Stock 173 Direct F7
transaction IDXX Restricted Stock Unit Options Exercise $0 -161 -50% $0.000000 160 14 Feb 2024 Common Stock 161 Direct F8
transaction IDXX Restricted Stock Unit Options Exercise $0 -204 -33% $0.000000 408 14 Feb 2024 Common Stock 204 Direct F9
transaction IDXX Restricted Stock Unit Options Exercise $0 -220 -25% $0.000000 660 14 Feb 2024 Common Stock 220 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 13.2470 shares purchased under the Issuer Employee Stock Purchase Plan on December 29, 2023.
F2 Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
F3 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
F4 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
F5 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021.
F8 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F9 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F10 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.